Benjamin Paluch

Stock Analyst at Roth MKM

(0.90)

# 3,719

Out of 4,944 analysts

3

Total ratings

33.33%

Success rate

-7.48%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Benjamin Paluch

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	CGON CG Oncology	Initiates: Buy	$65	$26.49	+145.38%	1	Aug 27, 2024
	REPL Replimune Group	Initiates: Buy	$17	$5.09	+233.99%	1	Aug 27, 2024
	GNLX Genelux	Initiates: Buy	$10	$3.20	+212.50%	1	Aug 27, 2024

CG Oncology

Aug 27, 2024

Initiates: Buy

Price Target: $65

Current: $26.49

Upside: +145.38%

Replimune Group

Aug 27, 2024

Initiates: Buy

Price Target: $17

Current: $5.09

Upside: +233.99%

Genelux

Aug 27, 2024

Initiates: Buy

Price Target: $10

Current: $3.20

Upside: +212.50%